Takashi Suda

Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Fujita Health University School of Medicine, Toyoake, Japan

Dr. Suda is a graduate of Fujita Health University. He received training in Thoracic Surgery at Fujita Health University Hospital. He was a Research Fellow in G. Alexander Patterson’s laboratory at Washington University from 1998 to 2001. After completing years working in Washington University joined the faculty at Fujita Health University Hospital and is currently an Associate Professor in the Department of Thoracic and Cardiovascular Surgery at Fujita Health University located in Toyoake, Japan. 

His specialty is minimally invasive surgery for lung cancer and mediastinal tumor. He conducted clinical research regarding the application of VATS and robot-assisted surgery, and assertively establish new surgical techniques. Started using VATS to treat primary lung cancer in January 2004 and to treat thymoma in 2005, he devised VATS to treat malignant mesothelioma in 2007, which has become a societal problem, and was the first to be successful. In 2009, the lung cancer patient was successfully treated using da Vinci robotic surgery. It was the first case in Japan. In 2012, Dr. Suda developed single-incision thymectomy using a subxiphoid approach, which is thymectomy performed through a single 3-cm long incision in the abdomen to treat thymoma and myasthenia gravis. This is a ground-breaking surgical technique that minimizes patient burden. In addition, in February 2014, he devised a method for using a subxiphoid approach with a da Vinci robot to perform thymectomy. This method is a new approach offering an excellent field of vision, excellent operability, and minimal invasiveness. Continued development in the future is expected. All of these important innovations have been described in an excellent series of manuscripts authored by Dr. Suda. He is an innovator in surgical management of lung cancer and diseases of the thymus.

Terms of Appointment: Feb 2016 - Jan 2018; Feb 2018 - Jan 2020